je.st
news
Mylan begins marketing HIV treatment
2015-01-16 18:27:04| Biotech - Topix.net
Canonsburg-based generic drug maker Mylan Inc. has begun marketing a medication that is used to treat hepatitis B and the human immunodeficiency virus. Mylan's 100-mg lamivudine tablets are a generic version of GlaxoSmithKline's Epivir-HBV, a medication approved in 1995 by the Food & Drug Administration.
Tags: marketing
treatment
begins
hiv
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||